CKD-701

· Chong Kun Dang Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-701, covering 2021-04-23 to 2021-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration [Phase 3]

See pricing